FTDI
ALXN

First Trust Direct Indexing’s Alexion Pharmaceuticals ALXN Stock Holding History

First Trust Direct Indexing’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,014
Closed -$1.1M – 691
2021
Q2 		$1.1M Buy
6,014
+3,110
+107% +$534K 0.17% 152
2021
Q1 		$444K Sell
2,904
-85
-3% -$13.1K 0.12% 238
2020
Q4 		$467K Buy
+2,989
New +$384K 0.13% 203

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

First Trust Direct Indexing's ALXN Position: Q3 2021 in Review

First Trust Direct Indexing sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,014 shares — an estimated $1.1M sold.

First Trust Direct Indexing first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $1.1M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • First Trust Direct Indexing reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 6,014 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.1M.
  • First Trust Direct Indexing first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • First Trust Direct Indexing's Alexion Pharmaceuticals position peaked at $1.1M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on First Trust Direct Indexing's 13F filing for Q3 2021, filed 8 Oct 2021.